1. Gander RJ, Gurney JA (1978) All-trans retinoic acid esters and amides. U.S. patent 4,108,880, August 22, 1978. Chem Abstr 88: 89892
2. Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM, Phillips SL, Henderson WR, Mullen LT et al (1979) N-(4-ydroxyphenyl)retinamide, a new retinoid for the prevention of breast cancer in the rat. Cancer Res 39: 1339–1346
3. McCormick DL, Mehta RG, Thompson CA, Dinger N, Caldwell JA, Moon RC (1982) Enhanced inhibition of mammary carcinogenesis by combination N-(4-hydrophenyl)retinamide and ovariectomy. Cancer Res 42: 508–512
4. McCormick DL, Moon RC (1986) Retinoid-tamoxifen interaction in mammry cancer chemoprevention. Carcinogenesis 7: 193–196
5. Ratko TA, Detrisac CJ, Dinger MN, Thomas CF, Kellof GJ, Moon RC (1989) Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res 49: 4472–4476